Lethal hyperparathyroid crisis: hazards of phosphate administration

Area of Science:

• Nephrology
• Endocrinology
• Pathology

Background:

• Hypercalcemia crisis, often linked to parathyroid adenoma, presents a critical medical condition requiring prompt management.
• Traditional treatments for hypercalcemia aim to reduce serum calcium levels effectively and safely.

Observation:

• Two patients with hypercalcemia crisis experienced fatal pulmonary insufficiency following phosphate administration.
• Pulmonary complications arose concurrently with elevated serum calcium and phosphate (Ca x PO4) product.
• Autopsy revealed extensive metastatic calcification within the pulmonary alveolar lining in both patients.

Findings:

• Phosphate administration appears to have precipitated the fatal pulmonary complications in these hypercalcemia patients.
• The mechanism involves a significant rise in the blood calcium-x-phosphate product, leading to widespread calcification.
• Phosphate may lower serum calcium levels primarily through intravascular precipitation, not by addressing the underlying calcium dysregulation.

Implications:

• The use of phosphates as a therapeutic agent for lowering calcium in hypercalcemia is strongly discouraged.
• Clinicians should exercise extreme caution and consider alternative strategies for managing hypercalcemia to avoid iatrogenic harm.
• This case highlights the critical importance of understanding the physiological consequences of therapeutic interventions in complex metabolic disorders.